SANA / Sana Biotechnology, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Sana Biotechnology, Inc.
US ˙ NasdaqGS ˙ US7995661045

Acțiuni restante 278,291,590 shares
Acțiuni Insider93.665.391 shares
Proprietatea din interior33,66 %
Total Insiders23
Scorul de sentimente din interior

Insider Sentiment Score găsește companiile cumpărate de persoane din interior.

Este rezultatul unui model cantitativ sofisticat, multifactorial, care identifică companiile cu cele mai înalte niveluri de acumulare de persoane interne. Modelul de scoring folosește o combinație a numărului net de persoane din interior care cumpără în ultimele 90 de zile, totalul acțiunilor cumpărate ca procent din flota și totalul acțiunilor deținute de insider. Numărul variază de la 0 la 100, numerele mai mari indicând un nivel mai ridicat de acumulare pentru semenii săi, iar 50 fiind media.

Frecvența actualizării: zilnic

Vedeți Top Picks Insiders, care oferă o listă a companiilor cu cea mai mare acumulare de persoane din interior.

Scorul de sentiment al ofițerului

Scorul de sentiment al ofițerilor găsește companii cumpărate de ofițerii corporativi.

Prin definiție, Ofițerii Corporativi sunt Corporate Insiders, dar spre deosebire de unii dintre ceilalți Insiders (10% Acționari și Membri ai Consiliului de Administrație), Ofițerii lucrează zilnic pentru companie și își folosesc banii atunci când tranzacționează . (10% acționari și membri ai consiliului de administrație sunt adesea administratori de fonduri care gestionează banii altor persoane.) Ca atare, tranzacțiile privilegiate efectuate de către ofițeri sunt mult mai semnificative și ar trebui tratate în mod corespunzător.

La fel ca Scorul Sentimentului Insider, Scorul Sentimentului Ofițerului este rezultatul unui model cantitativ sofisticat, multifactorial, care identifică companiile cu cele mai înalte niveluri de acumulare de ofițeri.

Frecvența actualizării: zilnic

Vedeți Top Picks Insiders, care oferă o listă a companiilor cu cel mai mare sentiment din interior.

Valori cheie ale insiderului

Acest card arată modul în care compania se clasifică de-a lungul diferitelor valori interne. Clasamentul percentilei arată cum se compară această companie cu alte companii de pe piețele din SUA. Clasamentele mai înalte indică situații mai bune.

De exemplu, este în general acceptat că cumpărarea din interior este un indicator pozitiv, astfel încât companiile cu mai multe achiziții din interior s-ar clasa mai sus decât companiile cu mai puține achiziții din interior (sau chiar vânzări din interior).

Numărul net de persoane din interior care cumpără (clasament)

0 ( )
5436 out of 10931

Numărul net de persoane din interior care cumpără este numărul total de persoane din interior care cumpără minus numărul total de persoane din interior care au vândut în ultimele 90 de zile. Rangul percentilei este afișat aici (interval de la 0 la 100%).

Procent din flota cumpărată de persoane din interior (clasament)

0.000% ( )
5373 out of 10786

Procent of Float Bought by Insiders este numărul total de acțiuni cumpărate de insiders minus numărul total de acțiuni vândute de insiders în ultimele 90 de zile, împărțit la flota totală și înmulțit cu 100.

Graficul privind tranzacțiile privilegiate

Sana Biotechnology, Inc. tranzacții privilegiate sunt prezentate în graficul următor. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. În general, este în general ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații materiale, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4.

Lista de persoane din interior și valori de profitabilitate

Acest tabel prezintă lista persoanelor din interior cunoscute și este generată automat din dosarele dezvăluite SEC. Pe lângă nume, cel mai recent titlu și desemnarea directorului, a ofițerului sau a proprietarului în proporție de 10%, oferim cele mai recente dețineri divulgate. În plus, atunci când este posibil, oferim performanța comercială istorică pentru persoane din interior. Performanța comercială istorică este o medie ponderată a performanței tranzacțiilor reale de cumpărare pe piață deschisă efectuate de către insider. Pentru mai multe informații despre cum se calculează, urmăriți acest webinar YouTube.

See our leaderboard of most profitable insider traders.

Insider Profit mediu (%) Acțiuni
Deținut
Despică
Ajustat
Noubar Afeyan 10% Owner - [10%] 11.585.199 0
Sunil Agarwal EVP, Head of Development & CMO - [O] 1.550.000 1.550.000
ARCH Venture Fund X, L.P. 10% Owner - [10%] 22.747.272 22.747.272
ARCH Venture Partners X, LLC 10% Owner - [10%] 11.718.750 22.747.272
Bilenker Joshua H. Director - [D] 20.000 20.000
Hans Edgar Bishop Director - [D] 5.848.503 5.848.503
Keith Crandell 10% Owner - [10%] 22.747.272 22.747.272
Insider Profit mediu (%) Acțiuni
Deținut
Despică
Ajustat
Bernard J Cassidy EVP & General Counsel - [O] 112.990 112.990
FMR LLC / Fidelity Management & Research 10% Owner - [10%] 4.541.572 4.541.572
Flagship Ventures Fund V General Partner LLC 10% Owner - [10%] 22.546.725 0
Flagship Ventures Management, Inc. 10% Owner - [10%] 0 0
Steven Gillis 10% Owner - [10%] 11.718.750 22.747.272
Nathan Hardy SVP, Chief Financial Officer - [O] 511.250 511.250
Steve Harr President & CEO, Director - [D] [O] 7.944.251 7.944.251
Christian Hordo EVP, Chief Business Officer - [O] 867.455 867.455
Insider Profit mediu (%) Acțiuni
Deținut
Despică
Ajustat
MacDonald James J. EVP & General Counsel - [O] 497.396 497.396
Richard Mulligan Director - [D] 2.698.121 2.698.121
Robert Nelsen Director, 10% Owner - [D] [10%] 22.761.125 22.761.125
Dhavalkumar Dhirajlal Patel EVP, Chief Scientific Officer - [O] 99.510 99.510
Mary Agnes Wilderotter Director - [D] 7.106 7.106
Wyrick Susan D. See Remarks - [O] 196.196 196.196
Patrick Y Yang Director - [D] 149.250 149.250
Maltzahn Geoffrey von Director - [D] 366.122 366.122

Report errors via our new Insider Auditing Tool

Înregistrări ale achizițiilor interne - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în SANA / Sana Biotechnology, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție și rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
2024-02-08 ARCH Venture Fund X, L.P. 727.272 5,5000 727.272 5,5000 3.999.996 22 11.2700 4.196.359 104,91
2024-02-08 ARCH Venture Fund X, L.P. 363.637 5,5000 363.637 5,5000 2.000.004
2024-02-08 ARCH Venture Fund X, L.P. 727.272 5,5000 727.272 5,5000 3.999.996
2022-03-21 Yang Patrick Y 28.000 7,3000 28.000 7,3000 204.400
2021-02-03 Bilenker Joshua H. 20.000 25,0000 20.000 25,0000 500.000

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate reprezintă acțiunile ajustate în funcție de divizarea.

SANA / Sana Biotechnology, Inc. Insider Trades
Înregistrări ale vânzărilor din interior - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în SANA / Sana Biotechnology, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție și rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
2025-01-08 FMR LLC / Fidelity Management & Research 100.000 6,1100 100.000 6,1100 611.000 90 1.3400 -477.000 -78,07
2025-01-08 FMR LLC / Fidelity Management & Research 25.000 6,5000 25.000 6,5000 162.500
2025-01-08 FMR LLC / Fidelity Management & Research 164.912 6,7100 164.912 6,7100 1.106.560
2025-01-08 FMR LLC / Fidelity Management & Research 1.000 7,2600 1.000 7,2600 7.260
2024-03-08 Yang Patrick Y 25.000 9,4520 25.000 9,4520 236.300
2023-06-07 Flagship Ventures Fund V General Partner LLC 177.240 6,2397 177.240 6,2397 1.105.924
2023-06-07 Flagship Ventures Fund V General Partner LLC 22.760 6,2397 22.760 6,2397 142.016
2023-06-06 Flagship Ventures Fund V General Partner LLC 181.461 6,3061 181.461 6,3061 1.144.311
2023-06-06 Flagship Ventures Fund V General Partner LLC 22.297 6,3061 22.297 6,3061 140.607

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate reprezintă acțiunile ajustate în funcție de divizarea.

SANA / Sana Biotechnology, Inc. Insider Trades
Istoricul tranzactiilor

Faceți clic pe pictograma link pentru a vedea istoricul complet al tranzacțiilor. Tranzacțiile raportate ca parte a unui plan de tranzacționare automată 10b5-1 vor avea un X în coloana marcată 10b-5.

Fişier
Data
Comerț
Data
Formă Insider Ticker Titlul de securitate Cod 10b5-1 Direct Exercițiu
Preț
Unitate
Preț
Unități
Schimbat
Valoare
Schimbat (1K)
Rămas
Opțiuni
Rămas
Acțiuni
2026-04-08 2026-04-06 4 Bishop Hans Edgar SANA Common Stock A - Award D 7.763 5.848.503
2026-03-27 3 PATEL DHAVALKUMAR DHIRAJLAL SANA Common Stock D 99.510
2026-03-10 2026-03-09 4 Harr Steve SANA Common Stock F - Taxes D 3,1000 -12.819 -40 7.944.251
2026-03-10 2026-03-09 4 Harr Steve SANA Common Stock F - Taxes D 3,1300 -11.526 -36 7.957.070
2026-03-10 2026-03-07 4 Harr Steve SANA Common Stock M - Exercise D 50.000 7.968.596
2026-03-10 2026-03-06 4 Harr Steve SANA Common Stock M - Exercise D 41.666 7.918.596
2026-03-10 2026-03-09 4 Wyrick Susan D. SANA Common Stock F - Taxes D 3,1000 -1.045 -3 196.196
2026-03-10 2026-03-09 4 Wyrick Susan D. SANA Common Stock F - Taxes D 3,1300 -3.342 -10 197.241
2026-03-10 2026-03-07 4 Wyrick Susan D. SANA Common Stock M - Exercise D 3.250 200.583
2026-03-10 2026-03-06 4 Wyrick Susan D. SANA Common Stock M - Exercise D 10.416 197.333
2026-03-04 2026-03-03 4 Wyrick Susan D. SANA Common Stock F - Taxes D 3,9100 -491 -2 186.917
2026-03-04 2026-03-02 4 Wyrick Susan D. SANA Common Stock M - Exercise D 1.525 187.408
2026-01-06 2026-01-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 6.157 5.840.740
2026-01-06 2026-01-05 4 Wyrick Susan D. SANA Common Stock F - Taxes D 4,2700 -2.407 -10 185.883
2026-01-06 2026-01-02 4 Wyrick Susan D. SANA Common Stock M - Exercise D 7.500 188.290
2025-12-16 2025-12-15 4 Wyrick Susan D. SANA Common Stock F - Taxes D 5,2200 -873 -5 180.790
2025-12-16 2025-12-13 4 Wyrick Susan D. SANA Common Stock M - Exercise D 3.400 181.663
2025-12-05 2025-12-04 4 Wyrick Susan D. SANA Common Stock F - Taxes D 4,4400 -2.565 -11 178.263
2025-12-05 2025-12-03 4 Wyrick Susan D. SANA Common Stock M - Exercise D 10.000 180.828
2025-12-05 2025-06-04 4 Wyrick Susan D. SANA Common Stock F - Taxes D 2,3200 -2.567 -6 167.828
2025-12-05 2025-06-03 4 Wyrick Susan D. SANA Common Stock M - Exercise D 10.000 170.395
2025-10-07 2025-10-06 4 Bishop Hans Edgar SANA Common Stock A - Award D 5.628 5.834.583
2025-07-08 2025-07-07 4 Bishop Hans Edgar SANA Common Stock A - Award D 7.842 5.828.955
2025-04-08 2025-04-07 4 Bishop Hans Edgar SANA Common Stock A - Award D 16.339 5.821.113
2025-03-10 2025-03-10 4 Harr Steve SANA Common Stock F - Taxes D 2,5600 -12.820 -33 7.876.930
2025-03-10 2025-03-07 4 Harr Steve SANA Common Stock M - Exercise D 50.000 7.889.750
2025-03-10 2025-03-10 4 Cassidy Bernard J SANA Common Stock F - Taxes D 2,5600 -2.833 -7 112.990
2025-03-10 2025-03-07 4 Cassidy Bernard J SANA Common Stock M - Exercise D 11.041 115.823
2025-03-10 2025-03-10 4 Wyrick Susan D. SANA Common Stock F - Taxes D 2,5600 -836 -2 157.395
2025-03-10 2025-03-07 4 Wyrick Susan D. SANA Common Stock M - Exercise D 3.250 158.231
2025-03-03 2025-03-03 4 Wyrick Susan D. SANA Common Stock F - Taxes D 2,5600 -490 -1 154.981
2025-03-03 2025-03-02 4 Wyrick Susan D. SANA Common Stock M - Exercise D 1.525 155.471
2025-01-10 2025-01-08 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP SANA Common Stock S - Sale I 7,2600 -1.000 -7 4.541.511
2025-01-10 2025-01-08 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP SANA Common Stock S - Sale I 6,7100 -164.912 -1.107 4.542.511
2025-01-10 2025-01-08 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP SANA Common Stock S - Sale I 6,5000 -25.000 -162 4.707.423
2025-01-10 2025-01-08 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP SANA Common Stock S - Sale I 6,1100 -100.000 -611 4.732.423
2025-01-07 2025-01-06 4 Bishop Hans Edgar SANA Common Stock A - Award D 14.285 5.804.774
2025-01-03 2025-01-02 4 Wyrick Susan D. SANA Common Stock F - Taxes D 1,6500 -1.566 -3 153.946
2025-01-03 2025-01-02 4 Wyrick Susan D. SANA Common Stock M - Exercise D 5.000 155.512
2024-11-21 3/A FMR LLC / Fidelity Management & Research FMR Capital, Inc. SANA Common Stock I 61
2024-10-15 3 Wyrick Susan D. SANA Common Stock D 147.512
2024-10-09 2024-10-07 4 Bishop Hans Edgar SANA Common Stock A - Award D 5.938 5.790.489
2024-09-26 2024-09-25 4 Mulligan Richard SANA Common Stock S - Sale D 3,8878 -150.000 -583 2.698.121
2024-09-26 2024-09-24 4 Mulligan Richard SANA Common Stock S - Sale D 4,0838 -150.000 -613 2.848.121
2024-07-08 2024-07-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 4.911 5.784.551
2024-04-08 2024-04-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 2.774 5.779.640
2024-04-08 3 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP SANA Common Stock I 4.832.423
2024-03-11 2024-03-08 4 Yang Patrick Y SANA Common Stock S - Sale D 9,4520 -25.000 -236 149.250
2024-02-12 2024-02-08 4 NELSEN ROBERT SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 NELSEN ROBERT SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 NELSEN ROBERT SANA Common Stock P - Purchase I 5,5000 363.637 2.000 10.667.387
2024-02-12 2024-02-08 4 CRANDELL KEITH SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 CRANDELL KEITH SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 CRANDELL KEITH SANA Common Stock P - Purchase I 5,5000 363.637 2.000 10.667.387
2024-02-12 2024-02-08 4 ARCH Venture Fund X, L.P. SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 ARCH Venture Fund X, L.P. SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 ARCH Venture Fund X, L.P. SANA Common Stock P - Purchase I 5,5000 363.637 2.000 10.667.387
2024-01-08 2024-01-05 4 Wilderotter Mary Agnes SANA Common Stock A - Award D 1.470 7.106
2024-01-08 2024-01-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 4.901 5.776.866
2023-12-18 2023-12-15 4 Hordo Christian SANA Common Stock S - Sale D 4,0013 -75.000 -300 867.455
2023-10-06 2023-10-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 6.925 5.771.965
2023-10-06 2023-10-05 4 Wilderotter Mary Agnes SANA Common Stock A - Award D 2.077 5.636
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI General Partner LLC SANA Common Stock J - Other I -70.813 0
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI, L.P. SANA Common Stock J - Other I -2.431.281 7.293.841
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship Ventures Fund V General Partner LLC SANA Common Stock J - Other I -1.181.745 0
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock J - Other I -345.069 1.035.208
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship Ventures Fund V, L.P. SANA Common Stock J - Other I -4.926.378 8.057.470
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship VentureLabs V, LLC SANA Common Stock J - Other I -2.825.989 8.615.337
2023-07-06 2023-07-05 4 Wilderotter Mary Agnes SANA Common Stock A - Award D 1.245 3.559
2023-07-06 2023-07-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 4.152 5.765.040
2023-06-08 2023-06-07 4 Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock S - Sale I 6,2397 -22.760 -142 1.380.277
2023-06-08 2023-06-07 4 Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. SANA Common Stock S - Sale I 6,2397 -177.240 -1.106 10.743.293
2023-06-08 2023-06-06 4 Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock S - Sale I 6,3061 -22.297 -141 1.403.037
2023-06-08 2023-06-06 4 Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. SANA Common Stock S - Sale I 6,3061 -181.461 -1.144 10.920.533
2023-05-26 2023-05-26 4 Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock S - Sale I 6,2265 -9.330 -58 1.425.334
2023-05-26 2023-05-26 4 Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. SANA Common Stock S - Sale I 6,2265 -72.670 -452 11.101.994
2023-05-26 2023-05-25 4 Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock S - Sale I 6,3522 -13.127 -83 1.434.664
2023-05-26 2023-05-25 4 Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. SANA Common Stock S - Sale I 6,3522 -102.245 -649 11.174.664
2023-05-26 2023-05-24 4 Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock S - Sale I 6,5652 -39.580 -260 1.447.791
2023-05-26 2023-05-24 4 Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. SANA Common Stock S - Sale I 6,5652 -308.290 -2.024 11.276.909
2023-04-06 2023-04-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 7.716 5.760.888
2023-04-06 2023-04-05 4 Wilderotter Mary Agnes SANA Common Stock A - Award D 2.314 2.314
2023-02-17 2021-02-03 4 Bilenker Joshua H. SANA Common Stock P - Purchase D 25,0000 20.000 500 20.000
2023-01-06 2023-01-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 6.702 5.753.172
2023-01-06 2023-01-05 4 NELSEN ROBERT SANA Common Stock A - Award D 536 1.353
2022-10-06 2022-10-05 4 NELSEN ROBERT SANA Common Stock A - Award D 321 817
2022-10-06 2022-10-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 4.012 5.746.470
2022-09-20 3/A Cassidy Bernard J SANA Common Stock D 92.781
2022-09-16 3 Cassidy Bernard J SANA Common Stock D 82.031
2022-07-07 2022-07-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 3.328 5.742.458
2022-07-07 2022-07-05 4 NELSEN ROBERT SANA Common Stock A - Award D 266 496
2022-06-15 2022-06-13 4 MacDonald James J. SANA Common Stock M - Exercise D 1,4800 66.796 99 497.396
2022-06-15 2022-05-13 4 MacDonald James J. SANA Common Stock A - Award D 4,2840 1.183 5 430.600
2022-04-15 2021-04-14 4 Harr Steve SANA Common Stock G - Gift D -167.000 7.839.750
2022-04-15 2021-04-14 4 Harr Steve SANA Common Stock G - Gift D -167.000 7.839.750
2022-04-06 2022-04-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 2.880 5.739.130
2022-04-06 2022-04-05 4 NELSEN ROBERT SANA Common Stock A - Award D 230 230
2022-03-22 2022-03-21 4 Yang Patrick Y SANA Common Stock P - Purchase D 7,3000 28.000 204 174.250
2022-03-08 2022-03-03 4 Harr Steve SANA Stock Options (Right to Buy) A - Award D 5,70 760.000 760.000
2022-03-08 2022-03-03 4 AGARWAL SUNIL SANA Stock Options (Right to Buy) A - Award D 5,70 250.000 250.000
2022-03-08 2022-03-03 4 Mulligan Richard SANA Stock Options (Right to Buy) A - Award D 5,70 250.000 250.000
2022-03-08 2022-03-03 4 Hordo Christian SANA Stock Options (Right to Buy) A - Award D 5,70 225.000 225.000
2022-03-08 2022-03-03 4 MacDonald James J. SANA Stock Options (Right to Buy) A - Award D 5,70 225.000 225.000
2022-03-08 2022-03-03 4 Hardy Nathan SANA Stock Options (Right to Buy) A - Award D 5,70 225.000 225.000
2022-02-23 2022-02-18 4 MacDonald James J. SANA Common Stock S - Sale D 6,2800 -333 -2 429.417
2022-02-23 2021-11-15 4 MacDonald James J. SANA Common Stock A - Award D 18,2325 1.000 18 429.750
2021-09-17 2021-09-16 4 AGARWAL SUNIL SANA Common Stock S - Sale D 26,0000 -1.627 -42 1.550.000
2021-09-17 2021-09-15 4 AGARWAL SUNIL SANA Common Stock S - Sale D 26,0695 -58.373 -1.522 1.551.627
2021-09-14 2021-09-10 4 Hordo Christian SANA Common Stock S - Sale D 25,0000 -1.477 -37 942.455
2021-09-10 2021-09-09 4 Hordo Christian SANA Stock Option (Right to Buy) M - Exercise D 1,48 -39.205 88.803
2021-09-10 2021-09-09 4 Hordo Christian SANA Common Stock S - Sale D 25,0081 -25.466 -637 943.932
2021-09-10 2021-09-09 4 Hordo Christian SANA Common Stock S - Sale D 25,0130 -39.205 -981 969.398
2021-09-10 2021-09-09 4 Hordo Christian SANA Common Stock M - Exercise D 1,4800 39.205 58 1.008.603
2021-09-07 2021-09-03 4 Hordo Christian SANA Stock Option (Right to Buy) M - Exercise D 1,48 -700 128.008
2021-09-07 2021-09-03 4 Hordo Christian SANA Common Stock S - Sale D 25,0000 -700 -18 969.398
2021-09-07 2021-09-03 4 Hordo Christian SANA Common Stock M - Exercise D 1,4800 700 1 970.098
2021-09-07 2021-09-02 4 Hordo Christian SANA Stock Option (Right to Buy) M - Exercise D 1,48 -6.558 128.708
2021-09-07 2021-09-02 4 Hordo Christian SANA Common Stock S - Sale D 25,0039 -1.400 -35 969.398
2021-09-07 2021-09-02 4 Hordo Christian SANA Common Stock S - Sale D 25,0019 -6.558 -164 970.798
2021-09-07 2021-09-02 4 Hordo Christian SANA Common Stock M - Exercise D 1,4800 6.558 10 977.356
2021-09-03 2021-09-01 4 Hordo Christian SANA Stock Option (Right to Buy) M - Exercise D 1,48 -1.134 135.266
2021-09-03 2021-09-01 4 Hordo Christian SANA Common Stock S - Sale D 25,0057 -3.002 -75 970.798
2021-09-03 2021-09-01 4 Hordo Christian SANA Common Stock S - Sale D 25,0036 -1.134 -28 973.800
2021-09-03 2021-09-01 4 Hordo Christian SANA Common Stock M - Exercise D 1,4800 1.134 2 974.934
2021-09-01 2021-08-30 4 Hordo Christian SANA Stock Option (Right to Buy) M - Exercise D 1,48 -1.100 136.400
2021-09-01 2021-08-30 4 Hordo Christian SANA Common Stock S - Sale D 25,0183 -1.200 -30 973.800
2021-09-01 2021-08-30 4 Hordo Christian SANA Common Stock S - Sale D 25,0100 -1.100 -28 975.000
2021-09-01 2021-08-30 4 Hordo Christian SANA Common Stock M - Exercise D 1,4800 1.100 2 976.100
2021-04-27 2021-04-21 4 NELSEN ROBERT SANA Common Stock J - Other I 12.500 12.500
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -11.585.199 0
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -11.441.326 0
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.725.122 0
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -1.487.371 0
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Common Stock C - Conversion I 11.585.199 11.585.199
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Common Stock C - Conversion I 11.441.326 11.441.326
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Common Stock C - Conversion I 9.725.122 9.725.122
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Common Stock C - Conversion I 1.487.371 1.487.371
2021-02-10 2021-02-08 4 Bishop Hans Edgar SANA Series B Convertible Preferred Stock C - Conversion D -156.250 0
2021-02-10 2021-02-08 4 Bishop Hans Edgar SANA Series A-2 Convertible Preferred Stock C - Conversion D -800.000 0
2021-02-10 2021-02-08 4 Bishop Hans Edgar SANA Series A-1 Convertible Preferred Stock C - Conversion D -1.075.000 0
2021-02-10 2021-02-08 4 Bishop Hans Edgar SANA Common Stock C - Conversion D 2.031.250 5.736.250
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT SANA Series A-2 Convertible Preferred Stock C - Conversion I -366.122 0
2021-02-10 2021-02-08 4 von Maltzahn Geoffrey SANA Series A-2 Convertible Preferred Stock C - Conversion D -1.464.488 0
2021-02-10 2021-02-08 4 von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT SANA Common Stock C - Conversion I 366.122 366.122
2021-02-10 2021-02-08 4 von Maltzahn Geoffrey SANA Common Stock C - Conversion D 1.464.488 1.464.488
2021-02-10 2021-02-08 4 Harr Steve SANA Series B Convertible Preferred Stock C - Conversion D -156.250 0
2021-02-10 2021-02-08 4 Harr Steve SANA Series A-2 Convertible Preferred Stock C - Conversion D -800.000 0
2021-02-10 2021-02-08 4 Harr Steve SANA Series A-1 Convertible Preferred Stock C - Conversion D -1.075.000 0
2021-02-10 2021-02-08 4 Harr Steve SANA Common Stock C - Conversion D 2.031.250 8.173.750
2021-02-10 2021-02-08 4 MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10 SANA Series B Convertible Preferred Stock C - Conversion I -7.812 0
2021-02-10 2021-02-08 4 MacDonald James J. SANA Series A-1 Convertible Preferred Stock C - Conversion D -93.750 0
2021-02-10 2021-02-08 4 MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10 SANA Common Stock C - Conversion I 7.812 7.812
2021-02-10 2021-02-08 4 MacDonald James J. SANA Common Stock C - Conversion D 93.750 428.750
2021-02-05 2021-02-03 4 NELSEN ROBERT SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 von Maltzahn Geoffrey SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 Bishop Hans Edgar SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 AGARWAL SUNIL SANA Stock Option (Right to Buy) A - Award D 25,00 48.000 48.000
2021-02-05 2021-02-03 4 Bilenker Joshua H. SANA Stock Option (Right to Buy) A - Award D 25,00 7.000 7.000
2021-02-05 2021-02-03 4 Cole Douglas G. SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 Wilderotter Mary Agnes SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 Seitz Michelle SANA Stock Option (Right to Buy) A - Award D 25,00 7.000 7.000
2021-02-05 2021-02-03 4 Yang Patrick Y SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 REICIN ALISE SANA Stock Option (Right to Buy) A - Award D 25,00 7.000 7.000
2021-02-03 3 AGARWAL SUNIL SANA Common Stock D 1.610.000
2021-02-03 3 NELSEN ROBERT See Footnotes SANA Common Stock I 147.500
2021-02-03 3 NELSEN ROBERT See Footnotes SANA Common Stock I 145.000
2021-02-03 3 GILLIS STEVEN See Footnotes SANA Common Stock I 145.000
2021-02-03 3 GILLIS STEVEN See Footnotes SANA Common Stock I 147.500
2021-02-03 3 ARCH Venture Partners X, LLC See Footnotes SANA Common Stock I 145.000
2021-02-03 3 ARCH Venture Partners X, LLC See Footnotes SANA Common Stock I 147.500
2021-02-03 3 Hordo Christian SANA Common Stock D 975.000
2021-02-03 3 Yang Patrick Y SANA Common Stock D 146.250
2021-02-03 3 MacDonald James J. SANA Common Stock D 335.000
2021-02-03 3 MacDonald James J. Held by the KOM Trust SANA Common Stock I 125.000
2021-02-03 3 MacDonald James J. Held by the NMM Trust SANA Common Stock I 125.000
2021-02-03 3 Mulligan Richard SANA Common Stock D 2.998.121
2021-02-03 3 Harr Steve Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015 SANA Common Stock I 682.500
2021-02-03 3 Harr Steve SANA Common Stock D 6.142.500
2021-02-03 3 Bishop Hans Edgar SANA Common Stock D 3.705.000
2021-02-03 3 Hardy Nathan SANA Common Stock D 511.250
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista